title: What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
authors.forename: Pierre
authors.initials: P
authors.lastname: Tattevin
authors.forename: Christophe
authors.initials: C
authors.lastname: Camus
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005334:Fever; D006801:Humans; D000069349:Linezolid; D009503:Neutropenia / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use*; D014640:Vancomycin / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid